ASX Announcement

Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment

Published: 13/10/20, 01:31pm (AEST)2 pages
Mesoblast Limited
MSB:ASXHealthcare

Recent MSB Announcements

Price Sensitive only